Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Statement

23 Apr 2025 07:00

RNS Number : 7480F
System1 Group PLC
23 April 2025
 

 

 

23 April 2025

 

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Final Quarter and Full Year Trading Update

 

 

System1, the marketing decision-making platform www.system1group.com today issues an update on trading for the quarter ("Q4") and financial year ended 31 March 2025 ("FY25").

 

Revenue £ million - unaudited

Q4

Q4

Q4

H2

H2

H2

Full Year

Full Year

Full Year

FY25

FY24

% YoY

FY25

FY24

% YoY

FY25

FY24

% YoY

Predict Your (data)

6.6

5.5

19%

14.7

10.7

37%

28.1

19.8

42%

Improve Your (data-led consultancy)

1.8

2.1

-15%

3.1

3.1

0%

6.5

5.0

29%

Platform Revenue

8.4

7.7

10%

17.9

13.9

29%

34.6

24.8

39%

Other consultancy (non-platform)

0.5

1.0

-48%

1.2

2.9

-57%

2.9

5.2

-45%

Total Revenue

8.9

8.7

3%

19.1

16.7

14%

37.4

30.0

25%

* All numbers in this announcement are unaudited and therefore may be subject to change.

Full Year Highlights

« Total Revenue of £37.4m, +25% YoY (FY24: £30.0m)

« Platform Revenue up by 39% YoY

« Over 300 new Platform clients produced £8.1m new Platform Revenue (FY24: £7.5m)

« Platform Net Revenue Retention 106% (FY24: 100%)

« US Revenue +49% YoY; UK + 28% YoY

« Ad testing Revenue +39% YoY

« Gross profit margin 88% (FY24: 87%)

« Adjusted EBITDA £6.5m (FY24: £4.4m)

« Adjusted PBT £5.2m (FY24: £3.1m, + £68% YoY), PBT £5.3m (FY24: £3.1m, +71% YoY)

« Free cash flow £4.2m. Year-end cash £12.9m.

 

 

Revenue

Total Q4 Revenue of £8.9m was 2% higher than the very strong equivalent quarter last year, lifting FY25 Total Revenue to £37.4m, up 25% year on year. Platform Revenue increased by 9% in Q4 and 39% for the year due to continued strong performance in the UK and the US. Platform Revenue comprised 94% of Revenue in Q4 and 92% for the year as a whole (Full year FY24: 83%). New business performance was strong throughout the year, with over 300 new platform clients providing 23% of full year Platform Revenue.

 

New business wins in Q4 included an international video streaming service, one of the world's top three wine and spirits sellers, a large discount retailer chain, a US biotech business, and a multinational quick service restaurant group. Ad testing revenue grew by 39% in the year; Innovation showed double-digit growth H2 on H1 but declined by 30% YoY, and Brand was 4% lower than in FY24. The relatively modest overall revenue growth in Q4 reflected recent global disruption, volatility and uncertainty in global markets. In spite of this, March was the highest revenue month of the financial year.

 

Profitability

The Gross Profit margin was consistently strong in each quarter, closing at 88% for the year (FY24: 87%). Based on the unaudited management accounts, Adjusted Profit before Taxation for the year ended 31 March 2025 is expected to amount to £5.2m, up £2.1m, 68% on FY24. The adjusted EBITDA margin of over 17% in a period of accelerated investment in growth (FY24: 14%), represents good progress towards the Group's at-scale goal of 30%.

 

Cash Generation

Net cash increased by £4.0m in H2 FY25 and £3.3m across the year, resulting in year-end net cash of £12.9m (FY24: £9.6m, H1 FY25: £8.9m). Free cash flow was £4.2m after £0.7m of property lease payments treated as depreciation; (FY24: £4.0m). A £0.6m dividend was paid in Q3.

 

Notice of FY results

The Company intends to publish its FY25 results on 9 July 2025. Details of the Investor Meet Company presentation will follow closer to the day of the results.

 

Outlook

While it is too early for us to gauge the effect that the current volatility in global markets will have on our clients' budgets, inevitably at this stage there is more downside than upside risk and we will provide a further update in our full year results. While we remain focused on continuing the profitable growth momentum in the business, replicating 40%+ platform revenue growth may be challenging in the current global economic and political climate, however we do anticipate continuing to deliver strong revenue growth. We strongly believe that with 25 years of advertising and innovation experience, and a methodology rooted in behavioural science, System1 is well placed to achieve our long-term goals by enabling the world's largest brands to create with confidence.

 

Commenting on the results, CEO James Gregory said: "This year we delivered 39% platform revenue growth, improved profitability and cash generation whilst investing substantially in our people, the US market, and our customer offering. We begin the new financial year with a clear plan to grow our business in the US and revitalise our Innovation product offering". 

 

 

Further information on the Company can be found at www.system1group.com.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 and as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

Tel: +44 (0)20 7524 8000

 

Simon Bridges / Andrew Potts / Harry Rees

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDSAIFFIE
Date   Source Headline
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.